多路复用
数字聚合酶链反应
生物信息学
计算生物学
多路复用
分析灵敏度
生物
计算机科学
聚合酶链反应
生物信息学
遗传学
基因
医学
电信
替代医学
病理
作者
Jolinda de Korne-Elenbaas,Lea Caduff,Adrian Lison,Rachel E. McLeod,Melissa Pitton,Charles Gan,Timothy R. Julian
标识
DOI:10.1093/lambio/ovae137
摘要
Abstract Quantitative PCR (qPCR) and digital PCR (dPCR) are applied for quantifying molecular targets in disease diagnostics, pathogen detection and ecological monitoring. Uptake of dPCR is increasing due to its higher quantification accuracy relative to qPCR which stems from its independence from standard curves and its increased resistance to PCR inhibitors. Throughput can be increased through multiplexing, which allows simultaneous quantification of multiple targets. However, multiplexing with dPCR faces unique challenges relative to qPCR. Here we describe the three-phase development process of non-competing multiplex dPCR assays using target-specific fluorescently-labeled hydrolysis probes. We highlight common challenges encountered, along with recommended solutions. Phase 1: In silico assay design; target-specific primers and probes are selected or designed, potential issues with primer and probe interactions are identified, and fluorophores and quenchers are chosen based on dPCR instrumentation. Phase 2: Wet-lab validation; assays are benchmarked using positive controls. Insufficient performance leads to assay redesign, as needed. Phase 3: Assay implementation; assay specificity and sensitivity is validated on relevant samples matrices. Finally, we provide recommendations on the future design and standardization of multiplexed dPCR assays, highlighting the need for better in silico predictions of assay performance, standardizing positive controls, and automating partition classification systems.
科研通智能强力驱动
Strongly Powered by AbleSci AI